SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-154455
Filing Date
2021-12-30
Accepted
2021-12-30 07:19:15
Documents
6
Period of Report
2021-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2136556d1_6k.htm 6-K 25437
2 EXHIBIT 10.1 tm2136556d1_ex10-1.htm EX-10.1 45046
3 EXHIBIT 10.2 tm2136556d1_ex10-2.htm EX-10.2 377326
4 EXHIBIT 10.3 tm2136556d1_ex10-3.htm EX-10.3 129322
5 EXHIBIT 10.4 tm2136556d1_ex10-4.htm EX-10.4 65698
6 EXHIBIT 99.1 tm2136556d1_ex99-1.htm EX-99.1 13786
  Complete submission text file 0001104659-21-154455.txt   657647
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 211530597
SIC: 2834 Pharmaceutical Preparations